Actrapid Insulin Penfill 3ml - Short-Acting Diabetes Treatment
Actrapid Insulin Penfill 3ml
Actrapid Insulin Penfill 3ml is a short-acting insulin designed to manage blood sugar levels in individuals with diabetes mellitus. This insulin is used in conjunction with a balanced diet and regular exercise to prevent complications such as kidney damage and blindness. It is typically administered 20-30 minutes before meals to effectively control postprandial blood sugar spikes.
Key Features- Short-acting insulin for Type 1 and Type 2 diabetes
- Administered via subcutaneous injection
- Used with Novo Nordisk insulin delivery systems
- Volume 3ml per cartridge
- Concentration 100 IU/ml
- Compatible with NovoFine or NovoTwist needles
Ideal for individuals requiring short-acting insulin to manage diabetes. Suitable for use in both Type 1 and Type 2 diabetes management plans.
Typical User/Industry ProfileIndividuals with diabetes, healthcare providers, and diabetes management clinics.
About the BrandActrapid is a product of Novo Nordisk, a global leader in diabetes care. With a commitment to innovation and quality, Novo Nordisk has pioneered advancements in insulin delivery systems, making them a trusted authority in diabetes management.
Original: $42.24
-65%$42.24
$14.78Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Actrapid Insulin Penfill 3ml
Actrapid Insulin Penfill 3ml is a short-acting insulin designed to manage blood sugar levels in individuals with diabetes mellitus. This insulin is used in conjunction with a balanced diet and regular exercise to prevent complications such as kidney damage and blindness. It is typically administered 20-30 minutes before meals to effectively control postprandial blood sugar spikes.
Key Features- Short-acting insulin for Type 1 and Type 2 diabetes
- Administered via subcutaneous injection
- Used with Novo Nordisk insulin delivery systems
- Volume 3ml per cartridge
- Concentration 100 IU/ml
- Compatible with NovoFine or NovoTwist needles
Ideal for individuals requiring short-acting insulin to manage diabetes. Suitable for use in both Type 1 and Type 2 diabetes management plans.
Typical User/Industry ProfileIndividuals with diabetes, healthcare providers, and diabetes management clinics.
About the BrandActrapid is a product of Novo Nordisk, a global leader in diabetes care. With a commitment to innovation and quality, Novo Nordisk has pioneered advancements in insulin delivery systems, making them a trusted authority in diabetes management.
